Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease
Authors:
Open Access
- 6 November 2014
- journal article
- research article
- Published by SAGE Publications in Vascular Medicine
- Vol. 19 (6) , 473-482
Abstract
Hypoxia inducible factor (HIF) stabilization by HIF-prolyl hydroxylase (PHD) inhibitors may improve ischemic conditions such as peripheral artery disease (PAD). This multicenter, randomized, placebo-controlled study evaluated the safety and efficacy of GSK1278863 (an oral PHD inhibitor) in subjects with PAD. The study assessed two active treatment paradigms: single dosing and subchronic daily dosing (300 mg single dose and 15 mg daily for 14 days, respectively). Neither regimen improved exercise performance compared with placebo (change from baseline in the 6-minute walk test (6MWT; feet), (GSK1278863, placebo): single dose (–46, –44), p=0.96; repeat dose (9, 8), p=0.99; change in number of contractions to onset of claudication (goniometry): single dose (4, –1), p=0.053; repeat dose (–2, 1), p=0.08). A calf-muscle biopsy substudy showed no increases in mRNA or protein levels of HIF target genes. More subjects receiving GSK1278863 than placebo experienced adverse events, particularly following the 300 mg single dose. Thus, assessing the safety of GSK1278863 in this setting would require a larger population exposed to the agent for a longer duration. These data do not support a benefit of GSK1278863 in PAD using the regimens tested. ClinicalTrials.gov Identifier: NCT01673555Keywords
This publication has 43 references indexed in Scilit:
- Heel-rise test in the assessment of individuals with peripheral arterial occlusive diseaseVascular Health and Risk Management, 2013
- You Can't Run From InflammationCirculation Research, 2012
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery DiseaseCirculation, 2012
- Exercise Rehabilitation in Peripheral Artery DiseaseCirculation, 2011
- Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent ClaudicationJAMA, 2009
- Prognostic Value of Functional Performance for Mortality in Patients With Peripheral Artery DiseaseJACC, 2008
- Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolismNature Genetics, 2008
- Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1Cardiovascular Research, 2007
- Capillary supply and muscle fibre types in patients with intermittent claudication: relationships between morphology and metabolismEuropean Journal of Clinical Investigation, 1980